Abstract | INTRODUCTION: MATERIALS AND METHODS: In this multi-center trial, pre-therapeutic GGT levels were examined in 692 patients with cervical cancer. GGT levels were correlated with clinico-pathological parameters. Patients were assigned to previously described GGT risk groups and uni- and multivariable survival analyses were performed. RESULTS: GGT serum levels were associated with FIGO stage (p<0.0001) and age (r=0.2, p<0.0001) but not with lymph node involvement (p=0.85), and histological type (p=0.98). High-risk GGT group affiliation (p=0.01 and p<0.0001) was associated with poor disease-free and overall survival in a univariate analysis, but not in a multivariable Cox-regression model (p=0.59 and p=0.171). We further investigated the association between prognosis and GGT and observed a linear correlation between GGT and prognosis. Therefore we were not able to identify a clear prognostic cut-off value for GGT in patients with cervical cancer. CONCLUSIONS:
|
Authors | Stephan Polterauer, Gerda Hofstetter, Christoph Grimm, Jasmin Rahhal, Mariella Mailath-Pokorny, Maria Kohl, Nicole Concin, Clemens Tempfer, Christian Marth, Alexander Reinthaller |
Journal | Gynecologic oncology
(Gynecol Oncol)
Vol. 122
Issue 3
Pg. 590-4
(Sep 2011)
ISSN: 1095-6859 [Electronic] United States |
PMID | 21664662
(Publication Type: Journal Article, Multicenter Study)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Biomarkers, Tumor
- gamma-Glutamyltransferase
|
Topics |
- Apoptosis
(physiology)
- Biomarkers, Tumor
(blood)
- Female
- Humans
- Middle Aged
- Neoplasm Staging
- Prognosis
- Survival Analysis
- Uterine Cervical Neoplasms
(enzymology, pathology)
- gamma-Glutamyltransferase
(blood)
|